Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Cash from Investing Activities (2016 - 2021)

Historic Cash from Investing Activities for BioCorRx (BICX) over the last 10 years, with Q4 2021 value amounting to -$11995.0.

  • BioCorRx's Cash from Investing Activities fell 32430.14% to -$11995.0 in Q4 2021 from the same period last year, while for Sep 2022 it was -$11995.0, marking a year-over-year increase of 7062.14%. This contributed to the annual value of -$49997.0 for FY2021, which is 44185.54% down from last year.
  • As of Q4 2021, BioCorRx's Cash from Investing Activities stood at -$11995.0, which was down 32430.14% from -$35985.0 recorded in Q3 2021.
  • In the past 5 years, BioCorRx's Cash from Investing Activities ranged from a high of $801.0 in Q3 2019 and a low of -$54968.0 during Q4 2019
  • Its 4-year average for Cash from Investing Activities is -$18854.6, with a median of -$11995.0 in 2021.
  • Per our database at Business Quant, BioCorRx's Cash from Investing Activities skyrocketed by 50050.0% in 2019 and then plummeted by 89900.12% in 2020.
  • BioCorRx's Cash from Investing Activities (Quarter) stood at -$26184.0 in 2018, then crashed by 109.93% to -$54968.0 in 2019, then surged by 94.86% to -$2827.0 in 2020, then tumbled by 324.3% to -$11995.0 in 2021.
  • Its last three reported values are -$11995.0 in Q4 2021, -$35985.0 for Q3 2021, and -$2017.0 during Q1 2021.